{
    "organizations": [],
    "uuid": "9f5d663ec97e3b88baacd0f12c22c724888c35a6",
    "author": "",
    "url": "https://www.reuters.com/article/brief-aralez-pharmaceuticals-posts-q4-lo/brief-aralez-pharmaceuticals-posts-q4-loss-per-share-0-68-idUSASC09RYJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Aralez Pharmaceuticals Posts Q4 Loss Per Share $0.68‍‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "  in 7 minutes BRIEF-Aralez Pharmaceuticals Posts Q4 Loss Per Share $0.68‍‍​ Reuters Staff   Aralez Pharmaceuticals Inc: * ARALEZ ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS * ‍TOTAL REVENUE FOR Q4 OF 2017 WERE $28.0 MILLION, AN INCREASE OF $8.0 MILLION, OR 40%, COMPARED TO $20.0 MILLION FOR SAME PERIOD OF 2016​ * QTRLY LOSS PER SHARE $0.68‍​ * ‍2018 NET REVENUES TO BE IN A RANGE OF $140 MILLION TO $160 MILLION​ * SEES ‍2018 ADJUSTED EBITDA TO BE IN A RANGE OF $35 MILLION TO $55 MILLION​  ",
    "published": "2018-03-13T13:11:00.000+02:00",
    "crawled": "2018-03-13T13:21:26.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "minute",
        "pharmaceutical",
        "post",
        "q4",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "aralez",
        "pharmaceutical",
        "inc",
        "aralez",
        "announces",
        "fourth",
        "quarter",
        "financial",
        "result",
        "revenue",
        "q4",
        "million",
        "increase",
        "million",
        "compared",
        "million",
        "period",
        "qtrly",
        "loss",
        "per",
        "share",
        "net",
        "revenue",
        "range",
        "million",
        "see",
        "adjusted",
        "ebitda",
        "range",
        "million"
    ]
}